Assessing the impact of organ-specific lesion dynamics on survival in patients with recurrent urothelial carcinoma treated with atezolizumab or chemotherapy

BACKGROUND: Tumor dynamics typically rely on the sum of the longest diameters (SLD) of target lesions, and ignore heterogeneity in individual lesion dynamics located in different organs. PATIENTS AND METHODS: Here we evaluated the benefit of analyzing lesion dynamics in different organs to predict s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerioui, M., Desmée, S., Mercier, F., Lin, A., Wu, B., Jin, J.Y., Shen, X., Le Tourneau, C., Bruno, R., Guedj, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718952/
https://www.ncbi.nlm.nih.gov/pubmed/34954496
http://dx.doi.org/10.1016/j.esmoop.2021.100346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718952/
https://www.ncbi.nlm.nih.gov/pubmed/34954496
http://dx.doi.org/10.1016/j.esmoop.2021.100346

Ejemplares similares